Cargando…

Potential drawbacks of frequent asymptomatic coronavirus disease 2019 (COVID-19) testing

Detalles Bibliográficos
Autores principales:	Lippi, Giuseppe, Henry, Brandon M., Sanchis-Gomar, Fabian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684016/ https://www.ncbi.nlm.nih.gov/pubmed/33115549 http://dx.doi.org/10.1017/ice.2020.1305

Ejemplares similares

Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities
por: Lippi, Giuseppe, et al.
Publicado: (2017)

Repeated Testing in SARS-CoV-2 Infection
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Putative impact of the COVID-19 pandemic on anxiety, depression, insomnia and stress
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Updates on laboratory investigations in coronavirus disease 2019 (COVID-19)
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Coronavirus Disease 2019–Associated Coagulopathy
por: Lippi, Giuseppe, et al.
Publicado: (2021)

In reply— Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Estimating the burden of mental health impairment after COVID-19
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

SARS-CoV-2 recurrent RNA positivity after recovering from coronavirus disease 2019 (COVID-19): a meta-analysis
por: Mattiuzzi, Camilla, et al.
Publicado: (2020)

Potential drawbacks of SARS-CoV-2 seroprevalence surveys
por: Lippi, G.
Publicado: (2021)

Possible drawbacks of relying only on molecular testing for diagnosing SARS-CoV-2 infections
por: Lippi, G., et al.
Publicado: (2022)

Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis()
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Statins and other drugs: Facing COVID-19 as a vascular disease
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection
por: Henry, Brandon Michael, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis
por: Aggarwal, Gaurav, et al.
Publicado: (2020)

COVID-19 and smoking: Considerations after two years
por: Lippi, Giuseppe, et al.
Publicado: (2023)

Active smoking and COVID-19: a double-edged sword
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA
por: Lippi, Giuseppe, et al.
Publicado: (2022)

COVID-19: unravelling the clinical progression of nature’s virtually perfect biological weapon
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Is COVID-19 impacting prostate cancer screening? A survey of prostate-specific antigen test requests during a local outbreak
por: Ferrari, Anna, et al.
Publicado: (2021)

CT-Determined Maximum Pulmonary Artery to Ascending Aorta Diameter Ratio in Nonsevere COVID-19 Patients
por: Abosamak, Mohammed Fawzi, et al.
Publicado: (2021)

Asymptomatic coronavirus disease 2019 (COVID-19) in hospitalized patients
por: Passarelli, Victor C., et al.
Publicado: (2020)

Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis
por: Henry, Brandon Michael, et al.
Publicado: (2020)

Cardiac Biomarkers in COVID-19: A Narrative Review
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Hemoglobin value may be decreased in patients with severe coronavirus disease 2019
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Drawbacks for Studies on the Essential Oil of Dracocephalum kotschyi
por: Quoc, Le Pham Tan
Publicado: (2023)

Identification and management of asymptomatic carriers of coronavirus disease 2019 (COVID‐19) in China
por: Peng, Jianhui, et al.
Publicado: (2020)

In Reply — Cardiorespiratory Fitness Attenuates the Impact of Risk Factors Associated With COVID-19 Hospitalization
por: Lavie, Carl J., et al.
Publicado: (2021)

Red blood cell distribution width: A marker of anisocytosis potentially associated with atrial fibrillation
por: Lippi, Giuseppe, et al.
Publicado: (2019)

Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Universal PCR screening for coronavirus disease 2019 in asymptomatic patients on admission
por: Nakamura, Itaru, et al.
Publicado: (2021)

Pediatric Coronavirus Disease 2019: Why Is It Less Severe and Frequent in Children than Adults?
por: Jadali, Zohreh
Publicado: (2021)

Benzodiazepines consumption may have increased during the COVID-19 pandemic
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

Physical activity - an important preanalytical variable
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2014)

“Ultra-sensitive” cardiac troponins: Requirements for effective implementation in clinical practice
por: Lippi, Giuseppe, et al.
Publicado: (2018)

Exploring the association between extra-cardiac troponin elevations and risk of future mortality
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Influence of chronic training workload on the hematological profile: a pilot study in sedentary people, amateur and professional cyclists
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Cardiac troponin elevation in patients with influenza virus infections
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i3gntj8sa89g7nhavv6hnv14em